Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Brainxell Inc
Profile last edited on: 1/12/22      CAGE: 7EV37      UEI: CFGFE23M73T7

Business Identifier: High-purity, iPSC-derived human neurons for R&D
Year Founded
2015
First Award
2016
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

455 Science Drive Suite 210
Madison, WI 53711
   (608) 220-3240
   info@brainxell.com
   www.brainxell.com/index.html
Location: Single
Congr. District: 02
County: Dane

Public Profile

Organized around bringing the most relevant neuronal cell models to researchers and with a focus on drug discovery R&D, BrainXell provides a range of high-purity, iPSC-derived human neurons. Founded in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park, the company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
2
Conversion Rate
40.00%
Phase I Dollars
$1,124,359
Phase II Dollars
$2,760,842
Total Awarded
$3,885,201

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $255,217
Project Title: Accelerating Functional Maturation of Human iPSC-Derived Microglia
2020 2 NIH $1,529,289
Project Title: Accelerating Functional Maturation of Human Neurons for High-Throughput Screening
2019 1 NIH $224,797
Project Title: Rapid Production of Regional and Disease Specific Human Astrocytes for Cns Drug Discovery
2018 2 NIH $1,673,621
Project Title: Large-Scale Production of High Purity Human Neurons for Cns Drug Discovery
2016 1 NIH $202,277
Project Title: Patient Motor Neuron Assay System for Als Drug Discovery

Key People / Management

  Shouming Du -- Chief Executive Officer

  Roxanne Alvarez -- Applications Scientist & Quality Control

  Zhong-Wei Du

  Benjamin Dungar -- Research Specialist

  Michael Hendrickson -- Project Manager

  Young Mook Lee -- Senior Research Scientist

  Ashley Massman -- Scientist

Company News

Sep 30 2016
BrainXell enters into Global Licensing Agreement for induced Pluripotent Stem (iPS) Cell Patent Technology with iPS Academia Japan, Inc.